Added to YB: 2025-08-15
Pitch date: 2025-08-14
CLPT [neutral]
ClearPoint Neuro, Inc.
-20.44%
current return
Author Info
MVC Investing is a long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$11.79
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
Clearpoint Neuro (CLPT): Q2 Earnings Review
CLPT (earnings update): Q2'25 rev $9.2M (+17% YoY), net loss ($0.21). B&D +10%, Nav +33%, Equip +11%. ClearPoint 3.0 software at 35 sites; PRISM gaining share. $41.5M cash post-financing. Key catalyst: 60+ biopharma partners advancing to FDA approvals, expanding TAM 20x. Huntington's disease w/70k patients represents largest near-term opportunity.
Read full article (8 min)